Alembic Pharmaceuticals

OverviewSuggest Edit

Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients). It is engaged in the macrolides segment of anti-infective drugs.
TypePublic
Founded1907
HQVadodara, IN
Websitealembicpharmaceuticals.com

Latest Updates

Employees (est.) (Apr 2022)12,160
Revenue (FY, 2021)₹52.8 B(+15%)
Share Price (May 2022)₹753.5(+3%)
Cybersecurity ratingFMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Alembic Pharmaceuticals

Chirayu Amin

Chirayu Amin

Chairman & CEO
Pranav Amin

Pranav Amin

Managing Director
Shaunak Amin

Shaunak Amin

Managing Director
R. K. Baheti

R. K. Baheti

Director - Finance & CFO
K. G. Ramanathan

K. G. Ramanathan

Independent Director
Pranav Parikh

Pranav Parikh

Independent Director
Show more

Alembic Pharmaceuticals Office Locations

Alembic Pharmaceuticals has offices in Vadodara and Mumbai
Vadodara, IN (HQ)
Alembic Rd, Gorwa
Mumbai, IN
2nd Floor , Prime Corporate Park, Behind ITC Grand Maratha Sheraton, Sahar Road, Andheri East, Ashok Nagar, Andheri East
Vadodara, IN
Old Padra Rd, Vidyutnagar Colony, IOC Nagar, Haripura
Show all (3)

Alembic Pharmaceuticals Financials and Metrics

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals's revenue was reported to be ₹52.76 b in FY, 2021
INR

Revenue (Q3, 2022)

12.7b

Gross profit (Q3, 2022)

9.3b

Net income (Q3, 2022)

1.6b

EBITDA (Q3, 2022)

2.6b

EBIT (Q3, 2022)

2.0b

Market capitalization (20-May-2022)

148.4b

Closing stock price (20-May-2022)

753.5

Cash (31-Mar-2022)

694.3m

EV

154.8b
Alembic Pharmaceuticals's current market capitalization is ₹148.4 b.
Annual
INRFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

31.2b39.3b45.9b52.8b

Cost of goods sold

(10.4b)(11.7b)(13.0b)(15.0b)

Gross profit

20.9b27.6b33.1b39.0b

R&D expense

(3.9b)(302.7m)(426.4m)(253.8m)
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Revenue

8.6b11.3b10.2b9.5b12.4b12.1b13.4b14.6b13.1b13.3b12.9b12.7b

Cost of goods sold

(2.6b)(2.7b)(2.5b)(2.0b)(2.7b)(3.0b)(3.4b)(3.1b)(2.9b)(3.9b)(3.3b)(3.4b)

Gross profit

6.1b8.6b7.7b7.5b9.7b9.1b10.0b11.5b10.2b9.4b9.6b9.3b

R&D expense

(1.2b)(1.4b)(1.1b)(1.4b)(1.3b)(1.4b)(1.8b)(1.5b)(1.7b)(1.7b)(1.5b)
INRFY, 2018FY, 2022

Cash

899.2m694.3m

Accounts Receivable

5.3b8.1b

Prepaid Expenses

1.7b250.8m

Inventories

7.3b16.1b
INRFY, 2018FY, 2022

Net Income

5.4b6.2b

Depreciation and Amortization

1.1b2.9b

Inventories

(1.0b)(1.2b)

Accounts Payable

2.6b366.7m
Show all financial metrics

Alembic Pharmaceuticals Revenue Breakdown

Embed Graph

Alembic Pharmaceuticals revenue breakdown by business segment: 100.0% from MANUFACTURE OF PHARMACEUTICALS

Alembic Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

F

38/100

SecurityScorecard logo

Alembic Pharmaceuticals Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Alembic Pharmaceuticals Online and Social Media Presence

Embed Graph

Alembic Pharmaceuticals News and Updates

Spasticity Treatment Market - 41% of Growth to Originate from North America| Evolving Opportunities with Allergan Plc & Alembic Pharmaceuticals Ltd. | Technavio

NEW YORK, April 22, 2022 /PRNewswire/ -- Spasticity Treatment Market Facts at a Glance- Total Pages: 120 Companies: 10+ – Including Allergan Plc, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Covis Pharma BV, Dr. Reddys Laboratories Ltd., Endo International Plc, F. Hoffmann...

Alembic Pharmaceuticals Frequently Asked Questions

  • When was Alembic Pharmaceuticals founded?

    Alembic Pharmaceuticals was founded in 1907.

  • Who are Alembic Pharmaceuticals key executives?

    Alembic Pharmaceuticals's key executives are Chirayu Amin, Pranav Amin and Shaunak Amin.

  • How many employees does Alembic Pharmaceuticals have?

    Alembic Pharmaceuticals has 12,160 employees.

  • What is Alembic Pharmaceuticals revenue?

    Latest Alembic Pharmaceuticals annual revenue is ₹52.8 b.

  • What is Alembic Pharmaceuticals revenue per employee?

    Latest Alembic Pharmaceuticals revenue per employee is ₹4.3 m.

  • Who are Alembic Pharmaceuticals competitors?

    Competitors of Alembic Pharmaceuticals include YiChang HEC ChangJiang Pharmaceutical, Noven Pharmaceuticals and Ferrer.

  • Where is Alembic Pharmaceuticals headquarters?

    Alembic Pharmaceuticals headquarters is located at Alembic Rd, Gorwa, Vadodara.

  • Where are Alembic Pharmaceuticals offices?

    Alembic Pharmaceuticals has offices in Vadodara and Mumbai.

  • How many offices does Alembic Pharmaceuticals have?

    Alembic Pharmaceuticals has 3 offices.